Fig. 5

Loss of expression of CCDC8 and GALNT9 correlates with relapse-free patient survival. Kaplan–Meier analysis of multiple gene expression studies via the prognoscan database revealed that in two separate studies low expression of a CCDC8 (p = 0.001) and b GALNT9 (p = 0.003) was associated with poor relapse free survival